Wuhan Hiteck Biological Pharma Co.,Ltd
300683.SZ
Price:
$29.51
Market Cap:
$3.86B
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye, an acyclovir dispensable tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository drug; Xunkeyuan, a tinidazole suppository drug; and Shufu, a nimodipine sustained release tablets. The company also provides measles virus and rubella virus nucleic acid detection kit; mycoplasma isolation and identification kit and culture tube; bacteria...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-08-08
Stock Exchange
SHZ
Ticker
300683.SZ
PE Ratio
[-20.49]
ROE
[-8.03%]
Current Ratio
[4.60]
Dividend Yield
[0.44%]
Enterprise Value
[3.73B]
Dividend History
The ROE as of December 2025 (TTM) for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) is -8.03%
According to Wuhan Hiteck Biological Pharma Co.,Ltd’s latest financial reports and current stock price. The company's current ROE is -8.03%. This represents a change of 290.49% compared to the average of -2.06% of the last 4 quarters.
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) Historical ROE (quarterly & annually)
How has 300683.SZ ROE performed in the past?
The mean historical ROE of Wuhan Hiteck Biological Pharma Co.,Ltd over the last ten years is 4.57%. The current -8.03% ROE has changed -275.61% with respect to the historical average. Over the past ten years (40 quarters), 300683.SZ's ROE was at its highest in in the December 2016 quarter at 8.52%. The ROE was at its lowest in in the September 2025 quarter at -5.32%.
Average
4.57%
Median
2.39%
Minimum
-4.88%
Maximum
22.54%
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) ROE by Quarter and Year
Discovering the peaks and valleys of Wuhan Hiteck Biological Pharma Co.,Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 702.89%
Maximum Annual ROE = 22.54%
Minimum Annual Increase = -181.23%
Minimum Annual ROE = -4.88%
| Year | ROE | Change |
|---|---|---|
| 2024 | -2.90% | -40.53% |
| 2023 | -4.88% | 702.89% |
| 2022 | -0.61% | -151.04% |
| 2021 | 1.19% | -181.23% |
| 2020 | -1.46% | -140.72% |
| 2019 | 3.60% | -35.05% |
| 2018 | 5.54% | -36.34% |
| 2017 | 8.70% | -61.39% |
| 2016 | 22.54% | 61.18% |
| 2015 | 13.98% | -31.99% |
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) Average ROE
How has 300683.SZ ROE performed in the past?
The current ROE of Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.79%
5-year avg
-1.73%
10-year avg
4.57%
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) ROE vs. Peers
How is 300683.SZ’s ROE compared to its peers?
Wuhan Hiteck Biological Pharma Co.,Ltd’s ROE is greater than Harbin Medisan Pharmaceutical Co., Ltd. (-9.30%), less than Jinhe Biotechnology Co. Ltd. (5.45%), less than Yabao Pharmaceutical Group Co., Ltd (7.80%), greater than Honz Pharmaceutical Co., Ltd. (-17.26%), less than LanZhou Foci Pharmaceutical Co.,Ltd. (3.27%), less than Tibet Weixinkang Medicine Co., Ltd. (15.13%), greater than Zhejiang Starry Pharmaceutical Co.,Ltd. (-1.11%), greater than Zhuhai Rundu Pharmaceutical Co., Ltd. (-4.71%), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (10.08%), less than Tianjin Tianyao Pharmaceuticals Co., Ltd. (0.53%),
| Company | ROE | Market cap |
|---|---|---|
| -9.30% | $4.41B | |
| 5.45% | $4.71B | |
| 7.80% | $4.78B | |
| -17.26% | $5.05B | |
| 3.27% | $4.57B | |
| 15.13% | $4.87B | |
| -1.11% | $4.31B | |
| -4.71% | $4.60B | |
| 10.08% | $4.40B | |
| 0.53% | $4.75B |
Build a custom stock screener for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wuhan Hiteck Biological Pharma Co.,Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Wuhan Hiteck Biological Pharma Co.,Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Wuhan Hiteck Biological Pharma Co.,Ltd's ROE?
How is the ROE calculated for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ)?
What is the highest ROE for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ)?
What is the 3-year average ROE for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ)?
What is the 5-year average ROE for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ)?
How does the current ROE for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) compare to its historical average?